Drug Development

Edward Godek is manager of process and technical operations at Glatt Air Techniques, NJ, info.gat@glatt.com.

Chris O’Callaghan is senior product manager at Innopharma Technology, Dublin, Ireland, ocallaghanc@innopharmalabs.com.

Ian Jones, PhD, is founder and CEO of Innopharma Technology and Innopharma College of Applied Sciences, Dublin

Piyush Patel, is formulation technologies manager at Colorcon, PA, ppatel@colorcon.com.

Articles

Process analytical technology, based on monitoring particle size distribution and tracking coating thickness measurements in real time, can be used to predict the dissolution of polymer-coated multiparticulates.

Predicting Multiparticulate Dissolution in Real Time for Modified- and Extended- Release Formulations

Smruti P. Chaudhari, PhD, is a development scientist at Metrics Contract Services.

A case study reviews the reformulation and scale up of high drug load prototype using wet granulation process for a model formulation.

Wet Granulation Resolves Tablet Reformulation Challenges

The newly installed Harro Hӧfliger encapsulation unit expands Capsugel’s clinical- and commercial-scale capacity for dry powder inhalation projects.

Capsugel Installs New Encapsulation Unit for DPI Applications at Bend, Oregon Facility

The facility in Britley will now manufacture the company’s automated systems, enabling the company to better serve European markets and shorten the supply chain.

Parker Domnick Hunter to Manufacture Automated Bioprocessing Systems at UK Facility

Aptar Pharma’s ophthalmic squeeze dispenser is the first and only FDA-approved delivery system for prescription eye-treatment formulations without any preservatives.

Aptar Pharma’s Preservative-Free Multidose Dispenser Now Available with Allergan’s Eye-Care Medication in the US

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Will new generic drugs bring the cost of medicines down in the way policy makers hope?

More Generic Drug Approvals Not Enough

In a FDAVoice blog post, CBER Director Peter Marks discusses the new designation for cell therapies that treat life-threatening diseases.

Regenerative Medicine Advanced Therapy Designation Launches

Fisher BioServices will expand its CryoHub solution by co-locating it with the Cell and Gene Therapy Catapult manufacturing center for seamless supply chain management and to accelerate cell and gene therapy production.

Thermo Fisher Scientific and the Cell and Gene Therapy Catapult Form Pact to Optimize Advanced Therapy Supply Chain

Manufacturing will be carried out at the Pfizer Newbridge, Ireland, facility, which is now part of Pfizer CentreOne’s contract manufacturing network.

CMO Pfizer CentreOne Adds Highly Potent Solid Oral Dose to Portfolio

Richard Denk is Head Sales Containment at SKAN AG, www.skan.ch, Richard.Denk@skan.ch.

The new ISPE Containment Manual is a summary of the process involved in the manufacture of highly active or highly hazardous pharmaceutical substances.

Formulation and Drug Delivery